Atopic dermatitis to be related to higher levels of CRP

Published On 2022-01-12 13:46 GMT   |   Update On 2022-01-13 05:59 GMT
Advertisement

Atopic Dermatitis (AD) is known to affect 15%-20% of children worldwide. A recent study reported that adults with atopic dermatitis (AD) are at an increased risk of developing sleep disorders -- which is associated with higher levels of the inflammatory biomarker, C-reactive protein (CRP) that might substantially increase the risk of developing adverse cardiovascular outcomes and mortality.

 The findings of the study were presented during a late-breaking abstract session at the Revolutionizing Atopic Dermatitis virtual symposium. It is associated with a significant reduction in quality of life and numerous systemic comorbidities.  To fill this knowledge gap, Varsha Parthasarathy, Johns Hopkins Department of Dermatology, Baltimore MD, and colleagues aimed to examine the comorbidity burden of sleep disorders in AD patients and associate findings with inflammatory C-reactive protein and cardiovascular comorbidities in a large, multicenter cohort.

Advertisement

Adverse effects of AD is clearly not known, so far its effect on sleep isn't elucidated completely. However, there is no clarity on the association between AD, sleep disturbance, and systemic inflammation.

"This elevation in CRP may contribute to the systemic inflammatory impact of AD and substantially increase the risk of cardiovascular outcomes. Physicians are recommended to screen for these sleep-related comorbidities in all AD patients." they concluded.

For more information check out the full story on the link below:

CRP elevated in patients with atopic dermatitis and sleep disorders: Study 

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News